How to Get Rid of H. Pylori Without Antibiotics

No food, supplement, or alternative therapy has been shown to reliably eliminate an active H. pylori infection on its own. Antibiotic-based regimens remain the only treatments with proven eradication rates high enough for clinical use. That said, a growing body of research identifies natural compounds, probiotics, and experimental technologies that can lower bacterial counts, reduce treatment side effects, or boost the success rate of standard therapy when used alongside it. The distinction matters: “adjunct that helps” and “replacement that works alone” are very different claims, and most of what you will find marketed as a natural H. pylori cure falls squarely in the first category.

Why People Look for Alternatives

The standard approach to H. pylori is a combination of two or more antibiotics plus an acid-suppressing drug, taken for ten to fourteen days. It works well when the bacterial strain is susceptible to those antibiotics. The problem is that resistance is climbing. In a large study of clinical trial patients across the U.S. and Europe, about 22% of H. pylori isolates were resistant to clarithromycin, one of the most commonly prescribed drugs in first-line therapy, and roughly 69% were resistant to metronidazole.¹ A separate U.S.-focused analysis found clarithromycin resistance at about 32%, with treatment failure nearly three times more likely in resistant cases than in susceptible ones.²

Beyond resistance, plenty of people simply feel terrible on the antibiotics. Nausea, diarrhea, metallic taste, and abdominal pain are common enough that some patients abandon the course early, which further fuels resistance. These realities drive interest in anything that might either replace the drugs or at least make them work better with fewer side effects.

Probiotics as Add-On Therapy

Probiotics are the best-studied natural adjunct to standard H. pylori treatment, though the key word is “adjunct.” When added to antibiotics and acid suppressors, certain probiotic strains modestly improve eradication rates and substantially cut side effects. Used alone, they do not eliminate the infection.

An umbrella review pulling together multiple meta-analyses found that Lactobacillus species added to standard eradication therapy nudged cure rates up from about 73% to roughly 80%, while cutting the risk of side effects roughly in half. The effect on diarrhea was especially strong, with a 69% reduction in risk. Bifidobacterium species showed an even more dramatic association with successful treatment, with more than triple the odds of a cure compared to antibiotics alone.³ The evidence quality varied, so these numbers should be taken as suggestive rather than definitive, but the direction of the effect is consistent across many trials.

Saccharomyces boulardii, a probiotic yeast rather than a bacterium, has its own evidence base. A systematic review and meta-analysis found that adding S. boulardii to standard therapy improved eradication rates by about 9% and cut the risk of overall side effects by more than half, with particularly large reductions in diarrhea and constipation.⁴ Individual trials have echoed these findings. One randomized trial found the eradication rate was slightly higher in the S. boulardii group (about 88% versus 81%), though the difference did not reach statistical significance, while side effects like nausea, diarrhea, and bloating were meaningfully lower in the probiotic group.⁵

Some lab work hints at why certain probiotics are helpful. Specific strains of Lactobacillus salivarius directly inhibited H. pylori growth in vitro, including against antibiotic-resistant clinical isolates, suggesting the effect goes beyond just soothing the gut during treatment.⁶ But lab-dish results often look more impressive than what happens inside a living stomach, which is why probiotics still need antibiotics to get the job done.

Broccoli Sprouts and Sulforaphane

Sulforaphane, a compound concentrated in broccoli sprouts and other cruciferous vegetables, is one of the most intriguing natural substances studied against H. pylori. In a mouse model using transplanted human gastric tissue, sulforaphane completely eliminated the bacteria in most of the treated grafts.⁷ In a separate study, mice fed sulforaphane-rich broccoli sprouts showed reduced bacterial colonization, lower markers of inflammation, and protection against the type of tissue damage associated with gastric cancer risk. That protective effect depended on a specific cellular defense pathway, suggesting sulforaphane works partly by boosting the stomach’s own antioxidant and anti-inflammatory machinery.⁸

This is genuinely promising science, but a few caveats apply. Mouse stomachs are not human stomachs. The doses used in lab settings are often far higher than what you would get by eating broccoli sprouts with dinner. And crucially, even the animal studies describe reduced colonization and less inflammation, not complete cure. Nobody has shown in a rigorous human trial that eating broccoli sprouts alone clears the infection. Still, incorporating sulforaphane-rich foods during or after treatment is unlikely to hurt and may offer gastric protection.

Other Plant-Derived Compounds

Researchers have tested a long list of botanical compounds against H. pylori in the lab. A few stand out for having at least some evidence beyond a single petri dish.

Mastic gum, the resin of a tree native to the Greek island of Chios, attracted attention after a brief report in the New England Journal of Medicine noted it could kill H. pylori in vitro.⁹ Later analysis identified specific components in mastic gum’s essential oil that showed activity against multiple drug-resistant H. pylori strains, including ones isolated from patients with gastritis, ulcers, and gastric cancer.¹⁰ Mastic gum capsules are widely available as supplements, but human eradication trials remain small and inconsistent.

Curcumin, the active compound in turmeric, inhibited H. pylori growth in lab cultures across a range of concentrations and was effective at eradicating the bacteria in infected mice while also helping restore stomach tissue damage caused by the infection.¹¹ Curcumin’s notoriously poor absorption in the gut limits its practical usefulness when taken by mouth, and human data showing standalone eradication is scarce.

Green tea catechins show strong inhibition of H. pylori’s urease enzyme, which the bacterium relies on to survive in stomach acid. Among 77 plant-derived extracts tested, green tea showed the strongest urease inhibition.¹² Urease is critical to H. pylori’s survival strategy because it generates ammonia to neutralize stomach acid in the bacterium’s immediate environment.¹³ Blocking that enzyme is conceptually appealing, but tea drinkers have not been shown to clear infections through green tea consumption alone.

The In Vitro Problem

A recurring pattern runs through nearly all of this botanical research: impressive results in a lab dish, followed by weaker or inconsistent results in living organisms. A review of non-pharmacological H. pylori treatments noted that many food and plant extracts demonstrate anti-H. pylori activity in vitro but prove less effective in vivo.¹⁴ The reasons for this gap are practical rather than mysterious. H. pylori does not just float around in the stomach; it burrows into the mucus layer lining the stomach wall, where it is partially shielded from things you swallow. A compound might kill the bacterium in a test tube but never reach it in sufficient concentration inside a living stomach. Stomach acid, digestive enzymes, and the rapid transit of food through the gut all work against natural compounds reaching and maintaining the contact time needed to kill bacteria embedded in mucus.

This does not mean the research is useless. It means you should be skeptical of supplement marketing that cites “kills H. pylori” from a lab study as if that translates directly to a cure in humans. The journey from test tube to treatment is long, and most candidates do not survive it.

Honey, Cranberry, and Lactoferrin

Honey, particularly manuka honey, has genuine antibacterial properties against H. pylori in lab settings. All honey samples tested in one study produced zones of growth inhibition against the bacterium.¹⁵ Manuka honey specifically showed inhibitory activity equivalent to conventional medications in vitro, with no significant difference in time-kill curves.¹⁶ Earlier work confirmed that even a 5% manuka honey solution completely prevented visible H. pylori growth over 72 hours.¹⁷ The antibacterial mechanism in manuka honey appears to be distinct from ordinary honey’s hydrogen-peroxide-based activity, which is why regular honey showed less effect in the same experiments.

Cranberry juice works through a different mechanism entirely. Rather than killing H. pylori, a high-molecular-weight component in cranberry juice blocks the bacterium from adhering to the stomach lining.¹⁸ If the bacteria cannot stick, they are more easily washed away by normal gastric processes. This anti-adhesion property is conceptually interesting and has led to some small clinical trials of cranberry as an adjunct, though it has not been shown to eradicate established infections by itself.

Lactoferrin, an iron-binding protein found in milk and available as a supplement, has antibacterial and anti-inflammatory properties. Research has investigated adding oral lactoferrin to standard H. pylori eradication therapy, and while it may have supportive effects, lactoferrin alone does not eradicate the infection.¹⁹

Photodynamic Therapy and Light-Based Approaches

One of the more surprising avenues of research involves killing H. pylori with visible light. The bacterium naturally accumulates light-sensitive molecules called porphyrins, and when exposed to blue or violet light, these molecules generate reactive species that destroy the bacterial cell. In lab conditions, blue light killed the bacteria by a factor of 100,000.²⁰

In a small human study, blue light delivered endoscopically to the stomach lining reduced H. pylori colony counts by an average of 91%, with some patients approaching 99% reduction.²¹ Photodynamic therapy using external light-sensitizing agents like methylene blue has also shown the ability to eliminate free-swimming H. pylori.²²

This approach is genuinely novel and sidesteps antibiotic resistance entirely. The challenge is practicality: it currently requires endoscopy to deliver the light where it needs to go. That makes it an invasive and expensive procedure, not something you can do at home. As an option for patients who have failed multiple rounds of antibiotics due to resistant strains, though, it could eventually fill a real clinical niche.

Vaccines on the Horizon

Given that roughly half the world’s population carries H. pylori, preventing infection in the first place would be transformative. Vaccine development has been underway for years, with approaches including whole-cell vaccines, protein-based subunit vaccines, DNA vaccines, and live vector vaccines. Animal studies and some clinical trials have shown that H. pylori vaccines can significantly reduce bacterial load and stimulate cellular immunity.²³ No vaccine has yet reached routine clinical use, partly because H. pylori has evolved sophisticated ways to evade the immune system, making it a difficult target. But this remains an active field, and a working vaccine would eventually reduce the need for both antibiotics and the alternatives discussed here.

How to Know If It Is Working

Whatever approach you take, you need a reliable way to confirm whether H. pylori is still present afterward. Two non-invasive tests are considered the standard for both diagnosis and follow-up after treatment. The urea breath test works by having you swallow a labeled form of urea; if H. pylori is present, its urease enzyme breaks it down and the labeled carbon dioxide appears in your exhaled breath. The stool antigen test detects H. pylori proteins directly in a stool sample.²⁴ Both are useful for confirming whether eradication was successful.²⁵

The timing matters. Testing too soon after treatment can give false negatives because acid-suppressing drugs, antibiotics, and bismuth can temporarily suppress the bacteria without fully eliminating it. Guidelines generally call for waiting at least four weeks after finishing treatment before retesting, and stopping acid suppressors for a period beforehand. If you are trying natural approaches before or between antibiotic courses, the same testing rules apply. Do not assume the infection is gone because your symptoms improved; H. pylori can be present without causing noticeable symptoms, and it can also cause symptoms that wax and wane regardless of bacterial load.

What Happens After Eradication

One underappreciated aspect of H. pylori treatment is that clearing the infection can come with its own set of changes. A large Japanese study tracking patients before and after eradication found that the incidence of Barrett’s esophagus was higher in the three years following eradication than in the three years before it. The incidence of inflammatory bowel disease and the prevalence of allergic conditions were also higher after eradication, and the proportion of patients meeting criteria for metabolic syndrome showed a slight upward drift in the years following treatment.²⁶

This is not an argument against treating a symptomatic H. pylori infection. The bacterium is classified as a Group 1 carcinogen by the World Health Organization because of its link to gastric cancer, and untreated infections cause ulcers, chronic gastritis, and other serious problems. But it does complicate the picture for people who are asymptomatic carriers wondering whether they should treat “just in case.” H. pylori has co-evolved with humans for tens of thousands of years, and there is a growing conversation in gastroenterology about whether blanket eradication is always the right call. For anyone with active symptoms, ulcers, or a family history of stomach cancer, treating the infection is clearly the right move. For asymptomatic carriers, the decision is more nuanced and worth discussing with a gastroenterologist rather than self-treating with supplements.

Phage Therapy and Future Alternatives

Bacteriophages, viruses that infect and kill specific bacteria, represent another theoretically elegant solution to antibiotic resistance. H. pylori does have its own set of phages, and researchers have explored whether these could be weaponized as a therapeutic strategy.²⁷ The field is still at an early stage for this particular organism. Unlike phage therapies being tested for some other infections, H. pylori phage therapy has not reached human trials. The bacterium’s sheltered niche in the stomach mucus layer and the harsh acidic environment present unique delivery challenges. Still, as antibiotic resistance continues to narrow conventional options, this is one of several avenues that may eventually mature into a clinical tool.